| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.098 | 0.02 |